Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial

Yates, Max, Hamilton, Louise E., Elender, Frances, Dean, Loretta, Doll, Helen, MacGregor, Alex J., Thomas, Joegi and Gaffney, Karl (2015) Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial. Journal of Rheumatology, 42 (7). pp. 1177-1185. ISSN 0315-162X

Microsoft Word (FinalAnswersClean 10th Mar2015) - Accepted Version Download (73kB)

Abstract

To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.

Item Type:	Article
Uncontrolled Keywords:	ankylosing spondylitis,anti-tumor necrosis factor therapy,etanercept,randomized control trial
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Medicine and Health Sciences > Allied Health Professions (former - to 2013)
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Musculoskeletal Medicine Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Population Health
Depositing User:	Pure Connector
Date Deposited:	19 Aug 2015 15:16
Last Modified:	01 Jul 2025 00:22
URI:	https://ueaeprints.uea.ac.uk/id/eprint/54126
DOI:	10.3899/jrheum.141335

Downloads

Actions (login required)

View Item